Want to join the conversation?
$MYL's subsidiary Mylan Inc. agreed to the terms of $465MM settlement with the U.S. Department of Justice (DOJ) and other government agencies on Medicaid rebate classification for EpiPen Auto-Injector. The terms of the settlement do not provide for any finding of wrongdoing on the part of Mylan Inc. or any of its affiliated entities or personnel.
Still in yesterday’s $PZZA shock. I thought everyone had more pizza this football season!!
$TSLA stock downgraded to sell from hold by brokerage firm CFRA Research. However, the firm lifted the price target by $35 to $240.
$LB shares have plummeted after a disappointing quarter.